Business Context and Reporting Period
This Form 8-K Current Report was filed by Prothena Corporation plc on November 30, 2013. The filing discloses the entry into a material definitive agreement regarding the expansion of the Company's office facilities in South San Francisco, California.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The only financial data disclosed relates to the specific lease amendment:
- Additional Lease Cost: The Company expects to incur an additional $4.6 million in rent and lease-related operating expenses over the 7-year term of the amended lease.
- Lease Term: The amended lease expires on November 30, 2020.
- Payment Commencement: Rent and operating expenses for the new space are not due until April 1, 2015, unless the space is sublet prior to that date.
Material Changes
On November 30, 2013, Prothena Biosciences Inc., a wholly owned subsidiary, amended its existing lease with ARE-San Francisco No. 33, LLC. The amendment adds approximately 13,959 square feet of adjacent office space ("Extension Premises"). The rent rate per square foot for the new space matches the existing premises, and the landlord provides certain tenancy improvement allowances.
Outlook, Risks, and Management Commentary
The Company has the option to occupy or sublease the Extension Premises immediately. However, the obligation to pay rent and related operating expenses is deferred until April 1, 2015, subject to adjustments if the premises are sublet earlier. The parent company, Prothena Corporation plc, has guaranteed the obligations of its subsidiary under this agreement. No other risks, contingencies, or unusual items are disclosed in this filing.
Investor Verification Checklist
- Verify the total square footage of the existing premises to assess the scale of the 13,959 square foot expansion.
- Confirm the Company's current cash position to ensure it can support the deferred rent obligations starting in 2015.
- Review the full text of the Fourth Amendment to Lease (Exhibit 10.1) for specific details on tenancy improvement allowances and subletting conditions.
- Assess whether the expansion aligns with the Company's current headcount and operational growth plans.